Drug
Abciximab
Abciximab: highest development phase Post-Market, developed by Eli Lilly. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Eli Lilly
Trials
| Drug | Phase | Indication |
|---|---|---|
| Abciximab NCT00420030 | Post-Market | Shock, Cardiogenic |
Latest
No recent events.
Follow Abciximab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.